Literature DB >> 8344895

Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle.

J M Ren1, B A Marshall, E A Gulve, J Gao, D W Johnson, J O Holloszy, M Mueckler.   

Abstract

A line of transgenic mice was constructed in which the human Glut1 glucose transporter is overexpressed in skeletal muscle. Overexpression of Glut1 protein was evident in epitrochlearis, extensor digitorum longus (EDL), and quadriceps muscles, and resulted in 6.6-7.4-fold elevations in basal glucose transport activity as measured in isolated muscles in vitro. The elevated glucose transporter activity in the skeletal muscles of transgenic mice was associated with a 10-fold increase in glycogen concentration in EDL and quadriceps muscles that was not due to an increase in muscle glycogen synthase activity or a decrease in glycogen phosphorylase activity. The increased glucose transport activity also resulted in a 2-fold increase in muscle lactate concentration, with no increase in muscle glucose 6-phosphate. Despite a slight (10%) increase in muscle hexokinase activity, there was a 4-fold increase in total muscle free glucose in transgenic mice, indicating that hexokinase becomes rate-limiting for glucose uptake when the rate of glucose transport is very high. These results demonstrate that the muscle glycogen content can be dramatically elevated by increasing the muscle Glut1 protein level and that glucose transport is a rate-limiting step for muscle glucose disposal in normal, resting mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344895

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

Review 1.  Role of plasma membrane transporters in muscle metabolism.

Authors:  A Zorzano; C Fandos; M Palacín
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

2.  Prevention of fat-induced insulin resistance by salicylate.

Authors:  J K Kim; Y J Kim; J J Fillmore; Y Chen; I Moore; J Lee; M Yuan; Z W Li; M Karin; P Perret; S E Shoelson; G I Shulman
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 3.  Determinants of post-exercise glycogen synthesis during short-term recovery.

Authors:  Roy Jentjens; Asker Jeukendrup
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

4.  Re-patterning of skeletal muscle energy metabolism by fat storage-inducing transmembrane protein 2.

Authors:  Diego A Miranda; Timothy R Koves; David A Gross; Alexandra Chadt; Hadi Al-Hasani; Gary W Cline; Gary J Schwartz; Deborah M Muoio; David L Silver
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

5.  Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

Authors:  L Rossetti; A E Stenbit; W Chen; M Hu; N Barzilai; E B Katz; M J Charron
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

6.  Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4.

Authors:  J K Kim; A Zisman; J J Fillmore; O D Peroni; K Kotani; P Perret; H Zong; J Dong; C R Kahn; B B Kahn; G I Shulman
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

7.  Effect of sucrose and saturated-fat diets on mRNA levels of genes limiting muscle fatty acid and glucose supply in rats.

Authors:  Andreu Ferrer-Martínez; Mario Marotta; Marco Turini; Katherine Macé; Anna M Gómez-Foix
Journal:  Lipids       Date:  2006-01       Impact factor: 1.880

Review 8.  Muscle glycogen resynthesis after short term, high intensity exercise and resistance exercise.

Authors:  D D Pascoe; L B Gladden
Journal:  Sports Med       Date:  1996-02       Impact factor: 11.136

9.  Control of muscle glucose uptake: test of the rate-limiting step paradigm in conscious, unrestrained mice.

Authors:  Patrick T Fueger; Jane Shearer; Deanna P Bracy; Kelly A Posey; R Richard Pencek; Owen P McGuinness; David H Wasserman
Journal:  J Physiol       Date:  2004-12-02       Impact factor: 5.182

Review 10.  Current views on type 2 diabetes.

Authors:  Yi Lin; Zhongjie Sun
Journal:  J Endocrinol       Date:  2009-09-21       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.